Ziaee Mojtaba, Samini Morteza, Bolourtchian Mohammad, Ghaffarzadeh Mohammad, Ahmadi Maryam, Egbal Mohammad Ali, Khorrami Arash, Andalib Sina, Maleki-Dizaji Nasrin, Garjani Alireza
Department of Pharmacology, Science & Research Branch, Islamic Azad University, Tehran, Iran.
Chemistry and Chemical Engineering Research Center of Iran, Tehran, Iran.
Iran J Pharm Res. 2012 Winter;11(1):91-5.
Fibrates, as hypolipidemic drugs known as agonists of peroxisome proliferator-activated receptors, diminish inflammatory responses. Studies have shown that incorporation of a silicon atom into a drug structure improves its pharmacological potency, modifies its selectivity toward a given target, or changes its metabolic rate, in addition to increasing the lipophilicity of the compounds. A siliconized analog of clofibrate, ethyl-2-methyl-2-(4-(trimethylsilyl)phenoxy)propionate was synthesized, whereby the chlorine atom in the phenoxy ring was replaced by a trimethylsilyl group. The anti-inflammatory effects of the siliconized analog (silafibrate) were evaluated in an air-pouch model of inflammation and compared with those of clofibrate. Oral administration of both drugs produced a significant anti-inflammatory action by reducing carrageenan induced pouch leukocyte recruitment, exudates production, and granulated tissue weight. The silicon isostere of clofibrate has improved anti-inflammatory properties.
贝特类药物作为过氧化物酶体增殖物激活受体激动剂类的降血脂药物,可减轻炎症反应。研究表明,将硅原子引入药物结构除了能增加化合物的亲脂性外,还能提高其药理活性、改变其对特定靶点的选择性或改变其代谢速率。合成了氯贝丁酯的硅化类似物,即2-甲基-2-(4-(三甲基硅基)苯氧基)丙酸乙酯,其中苯氧基环中的氯原子被三甲基硅基取代。在气囊炎症模型中评估了该硅化类似物(西立贝特)的抗炎作用,并与氯贝丁酯进行了比较。口服这两种药物均通过减少角叉菜胶诱导的气囊白细胞募集、渗出物产生和肉芽组织重量而产生显著的抗炎作用。氯贝丁酯的硅类似物具有更好的抗炎特性。